2,201
Participants
Start Date
June 29, 2018
Primary Completion Date
March 13, 2025
Study Completion Date
February 15, 2035
Ticagrelor 90mg twice daily and ASA 75-100 mg daily
Assess whether ticagrelor 90 mg twice daily and ASA 75-100 mg daily versus ASA 75-160 mg daily improves outcome after isolated coronary artery bypass grafting in patients with acute coronary syndrome
ASA 75-160 mg daily
Assess whether ticagrelor 90 mg twice daily and ASA 75-100 mg daily versus ASA 75-160 mg daily improves outcome after isolated coronary artery bypass grafting in patients with acute coronary syndrome
Aalborg University Hospital, Aalborg
Aarhus University Hospital, Aarhus
Rigshospitalet, Copenhagen
Odense University Hospital, Odense
Helsinki University Hospital, Helsinki
Kuopio University Hospital, Kuopio
Oulu University Hospital, Oulu
Tampere University Hospital, Tampere
Turku University Hospital, Turku
Landspítali University Hospital, Reykjavik
St. Olavs hospital, University Hospital, Bergen
Oslo University Hospital, Oslo
University Hospital of North Norway, Tromsø
Haukeland University Hospital, Trondheim
Sahlgrenska University Hospital, Gothenburg
Blekinge Hospital, Karlskrona
Linköping University Hospital, Linköping
Skåne University Hospital, Lund
Örebro University Hospital, Örebro
Karolinska University Hospital, Stockholm
University Hospital of Umeå, Umeå
Uppsala University Hospital, Uppsala
Collaborators (1)
Gothia Forum - Center for Clinical Trial
OTHER
Göteborg University
OTHER
Vastra Gotaland Region
OTHER_GOV